{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:28:58Z","timestamp":1761488938258},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.pt.2012.05.003","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T20:54:22Z","timestamp":1339793662000},"page":"307-310","source":"Crossref","is-referenced-by-count":14,"title":["An alternative form of melarsoprol in sleeping sickness"],"prefix":"10.1016","volume":"28","author":[{"given":"Peter G.E.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2012.05.003_bib0005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1172\/JCI200421052","article-title":"Human African trypanosomiasis of the CNS: current issues and challenges","volume":"113","author":"Kennedy","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pt.2012.05.003_bib0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.21429","article-title":"The continuing problem of human African trypanosomiasis (sleeping sickness) in sub-Saharan Africa","volume":"64","author":"Kennedy","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pt.2012.05.003_bib0015","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1371\/journal.pntd.0001007","article-title":"The human African trypanosomiasis control and surveillance programme of the World Health Organisation 2000\u20132009: the way forward","volume":"5","author":"Simarro","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2012.05.003_bib0020","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-3156.2005.01470.x","article-title":"Quantifying the level of under-detection of Trypanosome brucei rhodesiense sleeping sickness cases","volume":"10","author":"Odiit","year":"2005","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2012.05.003_bib0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/QCO.0b013e32833f9fd0","article-title":"Potential new drugs for human African trypanosomiasis: some progress at last","volume":"23","author":"Barrett","year":"2010","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.pt.2012.05.003_bib0030","series-title":"The Fatal Sleep","year":"2007"},{"key":"10.1016\/j.pt.2012.05.003_bib0035","first-page":"1","article-title":"Control and surveillance of African trypanosomiasis","volume":"881","author":"World Health Organisation","year":"1998","journal-title":"WHO Tech. Rep. Ser."},{"key":"10.1016\/j.pt.2012.05.003_bib0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijpara.2006.01.012","article-title":"Diagnostic and neuropathogenesis issues in human African trypanosomiasis","volume":"365","author":"Kennedy","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2012.05.003_bib0045","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1086\/374645","article-title":"Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis","volume":"187","author":"Lejon","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2012.05.003_bib0050","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1086\/429929","article-title":"Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II)","volume":"191","author":"Schmid","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2012.05.003_bib0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomized, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2012.05.003_bib0060","doi-asserted-by":"crossref","first-page":"e1001204","DOI":"10.1371\/journal.ppat.1001204","article-title":"A molecular mechanism for eflornithine resistance in African trypanosomes","volume":"6","author":"Vincent","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2012.05.003_bib0065","doi-asserted-by":"crossref","first-page":"e923","DOI":"10.1371\/journal.pntd.0000923","article-title":"Fexinidazole \u2013 a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness","volume":"4","author":"Torreele","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2012.05.003_bib0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2217\/fmb.11.44","article-title":"Development of novel drugs for human African trypanosomiasis","volume":"6","author":"Barrett","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.pt.2012.05.003_bib0075","doi-asserted-by":"crossref","first-page":"e1151","DOI":"10.1371\/journal.pntd.0001151","article-title":"SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis","volume":"5","author":"Jacobs","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2012.05.003_bib0080","doi-asserted-by":"crossref","first-page":"e1308","DOI":"10.1371\/journal.pntd.0001308","article-title":"Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis","volume":"5","author":"Rodgers","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2012.05.003_bib0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpharm.2005.09.003","article-title":"Melarsoprol-cyclodextrins inclusion complexes","volume":"306","author":"Gibaud","year":"2005","journal-title":"Int. J. Pharm."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492212000864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492212000864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T19:23:44Z","timestamp":1542914624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492212000864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1471492212000864"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2012.05.003","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}